Castle Biosciences, Inc (CSTL) Stock Price

18.11 ▼ -0.52 (-2.79%)
Open: 18.57 Vol: 41.33K Day's range: 17.81 - 18.57 May 13, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CSTL Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 18.17▼ 18.13▼ 18.14▼ 18.97▼ 22.45▼
MA10 18.18▼ 18.13▼ 18.25▼ 21.90▼ 23.43▼
MA20 18.13▼ 18.27▼ 18.61▼ 23.28▼ 29.28▼
MA50 18.16▼ 18.82▼ 20.80▼ 24.48▼ 26.86▼
MA100 18.23▼ 21.12▼ 22.70▼ 30.65▼ 25.98▼
MA200 18.56▼ 22.80▼ 23.59▼ 28.61▼ 23.93▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ 0.045▲ 0.107▲ -0.635▼ -1.405▼
RSI 44.657▼ 38.028▼ 30.268▼ 25.869▼ 30.685▼
STOCH 66.001     53.063     30.071     18.879▼ 20.394    
WILL %R -80.851▼ -67.742     -78.799▼ -96.203▼ -98.196▼
CCI 31.867     5.287     -53.528     -119.445▼ -172.901▼
Latest Filters Detected On CSTL
▼ RSI&STOCH $CSTL Oversold RSI + Stochastic Set Alert
▼ BREAK $CSTL Price Breaks 60 Days Low Set Alert
▼ BREAK $CSTL Price Breaks 30 Days Low Set Alert
▼ BREAK $CSTL Price Breaks 20 Days Low Set Alert
▼ BREAK $CSTL Price Breaks 10 Days Low Set Alert
Castle Biosciences, Inc News
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
Wednesday, May 13, 2026 04:19 AM
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company ...
Castle Biosciences targets $345M-$355M 2026 revenue as TissueCypher volumes grow 58% and AdvanceAD-Tx reaches ~650 orders
Thursday, May 07, 2026 01:43 AM
Guidance language tightened upward in Q1, with the 2026 revenue range raised to "$345 million to $355 million" from "$340 million to $350 million" (CFO Stokes), whereas Q4 introduced the initial 2026 ...
Castle Biosciences Q1 Earnings Call Highlights
Wednesday, May 06, 2026 05:34 PM
Castle Biosciences (NASDAQ:CSTL) reported first-quarter 2026 revenue of $83.7 million, supported by continued growth in what management described as its “core revenue drivers,” DecisionDx-Melanoma and ...
CSTL historical stock data
date open high low close volume
13/05/26 18.48 18.57 17.81 18.11 550,024
12/05/26 18.95 19.225 18.35 18.63 548,004
11/05/26 19.52 19.98 18.89 19.04 473,547
08/05/26 19.20 19.85 18.66 19.83 489,062
07/05/26 22.37 22.81 18.3101 19.24 1,894,632
06/05/26 24.66 25.19 24.25 24.75 701,839
05/05/26 25.43 25.43 24.43 24.60 384,511
04/05/26 24.73 25.70 24.73 25.52 215,892
01/05/26 24.53 25.11 24.1503 24.81 168,208
30/04/26 24.50 24.90 24.13 24.49 284,070
Quote Details
52wk Low:14.59
52wk High:44.28
Vol:41.33K
Avg Vol(3m):6.4M
1Y Chng:+13.40%
1M Chng:-27.70%
Add to Watch List
More Information
Index US Composite
Market Cap. 577.48M